POSA150 Cost-Effectiveness Analysis of First-Line (1L) Systemic Treatments in Advanced Renal Cell Carcinoma (aRCC) in France
| Autor: | Tempelaar, S, Kroep, S, Marie, L, Juban, L, Kurt, M, Ejzykowicz, F, May, JR, Gaudin, AF, Dhanji, N, Branchoux, S |
|---|---|
| Zdroj: | In Value in Health January 2022 25(1) Supplement:S63-S63 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect